These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
246 related items for PubMed ID: 27294781
1. N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A. Yao G, Zhang S, Mahrhold S, Lam KH, Stern D, Bagramyan K, Perry K, Kalkum M, Rummel A, Dong M, Jin R. Nat Struct Mol Biol; 2016 Jul; 23(7):656-62. PubMed ID: 27294781 [Abstract] [Full Text] [Related]
2. Crystal Structure of Botulinum Neurotoxin A2 in Complex with the Human Protein Receptor SV2C Reveals Plasticity in Receptor Binding. Gustafsson R, Zhang S, Masuyer G, Dong M, Stenmark P. Toxins (Basel); 2018 Apr 12; 10(4):. PubMed ID: 29649119 [Abstract] [Full Text] [Related]
3. Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A. Benoit RM, Frey D, Hilbert M, Kevenaar JT, Wieser MM, Stirnimann CU, McMillan D, Ceska T, Lebon F, Jaussi R, Steinmetz MO, Schertler GF, Hoogenraad CC, Capitani G, Kammerer RA. Nature; 2014 Jan 02; 505(7481):108-11. PubMed ID: 24240280 [Abstract] [Full Text] [Related]
4. A camelid single-domain antibody neutralizes botulinum neurotoxin A by blocking host receptor binding. Yao G, Lam KH, Weisemann J, Peng L, Krez N, Perry K, Shoemaker CB, Dong M, Rummel A, Jin R. Sci Rep; 2017 Aug 07; 7(1):7438. PubMed ID: 28785006 [Abstract] [Full Text] [Related]
5. Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F. Fu Z, Chen C, Barbieri JT, Kim JJ, Baldwin MR. Biochemistry; 2009 Jun 23; 48(24):5631-41. PubMed ID: 19476346 [Abstract] [Full Text] [Related]
6. Crystal structure of the BoNT/A2 receptor-binding domain in complex with the luminal domain of its neuronal receptor SV2C. Benoit RM, Schärer MA, Wieser MM, Li X, Frey D, Kammerer RA. Sci Rep; 2017 Mar 02; 7():43588. PubMed ID: 28252640 [Abstract] [Full Text] [Related]
14. Structural and biochemical characterization of the protease domain of the mosaic botulinum neurotoxin type HA. Lam KH, Sikorra S, Weisemann J, Maatsch H, Perry K, Rummel A, Binz T, Jin R. Pathog Dis; 2018 Jun 01; 76(4):. PubMed ID: 29688327 [Abstract] [Full Text] [Related]
16. Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons. Dong M, Liu H, Tepp WH, Johnson EA, Janz R, Chapman ER. Mol Biol Cell; 2008 Dec 01; 19(12):5226-37. PubMed ID: 18815274 [Abstract] [Full Text] [Related]
17. Understanding peptide competitive inhibition of botulinum neurotoxin A binding to SV2 protein via molecular dynamics simulations. Chang S, He HQ, Shen L, Wan H. Biopolymers; 2015 Oct 01; 103(10):597-608. PubMed ID: 26178648 [Abstract] [Full Text] [Related]